Phase Ib dose-escalation/expansion trial of ribociclib in combination with everolimus and exemestane in postmenopausal women with HR+, HER2- advanced breast cancer

1. Bardia, A.
2. Modi, S.
3. Oliveira, M.
4. Cortes, J.
5. Campone, M.
6. Ma, B.
7. Dirix, L.
8. Weise, A.
9. Hewes, B.
10. Diaz-Padilla, I.
11. Han, Y.
12. Deshpande, P.
13. Samant, T.S.
14. Lorenc, K.R.
15. He, W.
16. Su, F.
17. Chavez-MacGregor, M.